Arbaclofen placarbil in GERD: a randomized, double-blind, placebo-controlled study.

For: All,

This study tested arbaclofen placarbil (a drug related to arbaclofen, which has also been studied for autism and neurodevelopmental conditions) as a treatment for acid reflux (GERD), finding it may help reduce heartburn in people who previously responded to standard acid-blocking medications, which may be relevant to families managing GI symptoms commonly seen in individuals with 16p11.2 differences.